Core Viewpoint - Universe Pharmaceuticals INC plans to consolidate its shares at a ratio of 40 ordinary shares into one ordinary share, effective March 24, 2025, which aims to enhance the company's share structure and potentially improve its market perception [1][2]. Company Overview - Universe Pharmaceuticals INC is a pharmaceutical producer and distributor based in Ji'an, Jiangxi, China, focusing on traditional Chinese medicine derivatives aimed at the elderly to improve their physical conditions and overall well-being [3]. - The company also distributes biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements from third-party manufacturers, with products available in 30 provinces across China [3]. Share Consolidation Details - The share consolidation will convert 40 pre-consolidation ordinary shares into one ordinary share with a new par value of US$11.25, with no fractional shares issued; any fractions will be rounded up [1][2]. - Post-consolidation, the authorized share capital will be US$140,625,000, divided into 11,250,000 ordinary shares and 1,250,000 preferred shares, both with a par value of US$11.25 [2].
Universe Pharmaceuticals INC Announces Share Consolidation